Ignite Creation Date:
2025-12-24 @ 11:32 PM
Ignite Modification Date:
2026-02-22 @ 10:36 PM
Study NCT ID:
NCT02099656
Status:
COMPLETED
Last Update Posted:
2017-09-06
First Post:
2014-03-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study Evaluating the Effects of Lebrikizumab on Airway Eosinophilic Inflammation in Participants With Uncontrolled Asthma
Sponsor:
Hoffmann-La Roche
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-11-06
Start Date Type:
ACTUAL
Primary Completion Date:
2016-10-13
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-10-13
Completion Date Type:
ACTUAL
First Submit Date:
2014-03-26
First Submit QC Date:
None
Study First Post Date:
2014-03-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-09-04
Last Update Post Date:
2017-09-06
Last Update Post Date Type:
ACTUAL